title: Increase in plasma concentration of amisulpride after addition of concomitant lithium.
authors.forename: Niels
authors.initials: N
authors.lastname: Bergemann
authors.forename: Fatima
authors.initials: F
authors.lastname: Abu-Tair
authors.forename: Kai R
authors.initials: KR
authors.lastname: Kress
authors.forename: Peter
authors.initials: P
authors.lastname: Parzer
authors.forename: Jürgen
authors.initials: J
authors.lastname: Kopitz
mesh_terms: D000328:Adult; D000077582:Amisulpride; D018692:Antimanic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001883:Borderline Personality Disorder / Q000188:drug therapy; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy; D013469:Sulpiride / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D013469:Sulpiride; D000077582:Amisulpride